Fortress Biotech, Inc. Long-Term Debt, Maturity, Year Two
Fortress Biotech, Inc. (FBIO) had Long-Term Debt, Maturity, Year Two of $6.87 million as of 2013-12-31, per its 10-K filed 2014-03-14.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2014-03-14
- 2013-12-31: Long-Term Debt, Maturity, Year Two $6.87M.
- 2012-12-31: Long-Term Debt, Maturity, Year Two $5.75M.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2013-12-31 | $6.87M 10-K · filed 2014-03-14 |
| 2012-12-31 | $5.75M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |